CenterBook Partners LP decreased its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 35.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,601 shares of the insurance provider's stock after selling 2,505 shares during the quarter. CenterBook Partners LP's holdings in Humana were worth $1,167,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in the business. HighTower Advisors LLC increased its holdings in Humana by 2.1% in the 3rd quarter. HighTower Advisors LLC now owns 8,992 shares of the insurance provider's stock worth $2,852,000 after buying an additional 187 shares in the last quarter. MML Investors Services LLC grew its holdings in Humana by 15.6% during the 3rd quarter. MML Investors Services LLC now owns 4,737 shares of the insurance provider's stock worth $1,500,000 after acquiring an additional 638 shares in the last quarter. LRI Investments LLC grew its position in shares of Humana by 1,021.4% in the 3rd quarter. LRI Investments LLC now owns 157 shares of the insurance provider's stock worth $50,000 after buying an additional 143 shares during the last quarter. Coldstream Capital Management Inc. boosted its stake in Humana by 27.3% in the 3rd quarter. Coldstream Capital Management Inc. now owns 3,318 shares of the insurance provider's stock worth $1,032,000 after purchasing an additional 712 shares in the last quarter. Finally, Toronto Dominion Bank boosted its holdings in shares of Humana by 1.3% in the 3rd quarter. Toronto Dominion Bank now owns 59,992 shares of the insurance provider's stock valued at $19,002,000 after acquiring an additional 754 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on HUM shares. JPMorgan Chase & Co. cut their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Robert W. Baird boosted their target price on Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research report on Tuesday. Morgan Stanley cut their price target on Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a report on Wednesday, February 12th. StockNews.com raised shares of Humana from a "hold" rating to a "buy" rating in a research note on Monday, April 7th. Finally, Barclays lifted their price target on shares of Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a research note on Friday, April 11th. Seventeen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, Humana currently has a consensus rating of "Hold" and a consensus price target of $284.90.
Read Our Latest Report on HUM
Humana Price Performance
Shares of Humana stock traded up $1.07 on Wednesday, reaching $287.85. The company's stock had a trading volume of 282,395 shares, compared to its average volume of 1,628,412. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a 50-day moving average price of $265.57 and a 200-day moving average price of $270.22. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a market capitalization of $34.74 billion, a P/E ratio of 28.93, a PEG ratio of 2.05 and a beta of 0.62.
Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Analysts expect that Humana Inc. will post 16.47 EPS for the current year.
Humana Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.23%. The ex-dividend date of this dividend is Friday, March 28th. Humana's payout ratio is 35.58%.
About Humana
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Further Reading
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
